1. Home
  2. ESPR vs NBH Comparison

ESPR vs NBH Comparison

Compare ESPR & NBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$2.61

Market Cap

731.9M

Sector

Health Care

ML Signal

HOLD

Logo Neuberger Berman Municipal Fund Inc.

NBH

Neuberger Berman Municipal Fund Inc.

HOLD

Current Price

$10.04

Market Cap

298.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESPR
NBH
Founded
2008
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
731.9M
298.0M
IPO Year
2013
2002

Fundamental Metrics

Financial Performance
Metric
ESPR
NBH
Price
$2.61
$10.04
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$7.60
N/A
AVG Volume (30 Days)
5.2M
94.4K
Earning Date
05-05-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
60.71
N/A
EPS
N/A
N/A
Revenue
$403,135,000.00
N/A
Revenue This Year
$2.92
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
21.31
N/A
52 Week Low
$0.73
$9.47
52 Week High
$4.18
$10.64

Technical Indicators

Market Signals
Indicator
ESPR
NBH
Relative Strength Index (RSI) 41.86 43.06
Support Level $2.37 $9.75
Resistance Level $3.02 $10.42
Average True Range (ATR) 0.18 0.15
MACD 0.03 0.00
Stochastic Oscillator 37.62 44.84

Price Performance

Historical Comparison
ESPR
NBH

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a commercial-stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs. It has developed and is commercializing U.S. Food and Drug Administration, or FDA, approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease (or CVD and are struggling with elevated low-density lipoprotein cholesterol, or LDL-C. The Company views its operations and manages its business in one operating segment, which is the business of researching, developing, and commercializing therapies for the treatment of patients with elevated LDL-C. The company depends almost entirely on the success of two products, the bempedoic acid tablet and the bempedoic acid/ezetimibe combination tablet.

About NBH Neuberger Berman Municipal Fund Inc.

Neuberger Berman Municipal Fund Inc is a closed-end management investment company that invests mainly in municipal securities. The company aims to provide common stockholders a high level of current income exempt from Federal income tax.

Share on Social Networks: